Ryan Preblick
Director of Finance/CFO at INDIVIOR PLC
Net worth: 1 M $ as of 2024-03-30
Profile
Ryan Preblick is currently the Chief Financial Officer & Executive Director at Indivior PLC since 2020.
He is also currently the Chief Financial Officer, Secretary & Treasurer at Opiant Pharmaceuticals, Inc. Mr. Preblick completed his undergraduate degree at The Pennsylvania State University and holds an MBA from the University of Richmond.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INDIVIOR PLC
0.05% | 2024-03-14 | 68,386 ( 0.05% ) | 1 M $ | 2024-03-30 |
Ryan Preblick active positions
| Companies | Position | Start |
|---|---|---|
| INDIVIOR PLC | Director of Finance/CFO | 2020-06-28 |
| OPIANT PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Training of Ryan Preblick
| The Pennsylvania State University | Undergraduate Degree |
| University of Richmond | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| INDIVIOR PLC | Health Technology |
| Private companies | 1 |
|---|---|
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
- Stock Market
- Insiders
- Ryan Preblick
